Latest filing published 03 Aug 2021 for Rani Therapeutics Holdings, Inc., €1.5M.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Moreno Isidoro Quiroga: trading record in brief
Moreno Isidoro Quiroga, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Enphase Energy, Inc. and Rani Therapeutics Holdings, Inc. The record holds 12 filings, for trades running from 15 November 2019 to 3 August 2021.
In open-market terms, that means 11 purchases worth €81.2M on one side and 1 sale worth €746.3M on the other. Taken together, the sales exceed the purchases by €665.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2021 to date brings 3 purchases and no sales.
Half of the purchases are above €2.6M and half below. On 8 out of 11 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 3 August 2021, reports an open-market purchase of €25.3M in Rani Therapeutics Holdings, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Moreno Isidoro Quiroga
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 158,904 shares@ US$11.2525100.0% of flowClass A Common StockSEC:0001104659-21-099595:0Canonical exit: 28 Oct 2021 (T+90)
1 of 1 declaration
